185
Views
29
CrossRef citations to date
0
Altmetric
Infections

Evaluation of IL-12 serum level in patients with recalcitrant multiple common warts, treated by intralesional tuberculin antigen

, , &
Pages 264-267 | Received 14 Dec 2012, Accepted 06 Jan 2013, Published online: 06 May 2013

References

  • Lipke MM. An armamentarium of treatments. Clin Med Res. 2006;4:273–293.
  • Scheinfeld N, Lehman DS. An evidence based review of medical and surgical treatments of genital warts. Dermatol Online J. 2006;12:5–8.
  • Gupta S, Malhotra AK, Sharma VK. Intralesional immunotherapy with killed Mycobacterium W vaccine for the treatment of ano-genital warts: an open label pilot study. J Eur Acad Dermatol Venereol. 2008;22:1089–1093.
  • Johnson SM, Horn TD. Intralesional immunotherapy for warts using a combination of skin test antigens: A safe and effective therapy. J Drugs Dermatol. 2004;3:263–265.
  • Kus S, Ergun T, Gun D, Akin O. Intralesional tuberculin for treatment of refractory warts. J Eur Acad Dermatol Venereol. 2005;19:515–516.
  • Horn TD, Johnson SM, Helm RM. Intralesional immunotherapy of warts with mumps, Candida, and trichophytin skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. 2005;141:589–594.
  • Nofal A, Nofal E. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol. 2010;24:1166–1170.
  • Eassa BI, Abou-Bakr AA, El-Khalawany MA. Intradermal injection of PPD as a novel approach of immunotherapy in anogenital warts in pregnant women. Dermatol Ther. 2011;24:137–143.
  • Johnson SM, Roberson PK, Horn TD. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol. 2001;137:451–455.
  • Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida and trichophyton skin test antigens: a single-blinded, randomized and controlled trial. Arch Dermatol. 2005;141:589–594.
  • Scott M, Stites DP, Moscicki AB. Th-1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol. 1999;6:751–755.
  • Scott M, Nakagawa M, Moscicki AB. Cell mediated immune response to human papilloma virus infection. Clin Diagn Immunol. 2001;8:209–213.
  • King M, Johnson SM, Horn TD. Intralesional immunotherapy for genital warts. Arch Dermatol. 2005;141:1606–1607.
  • Wananukul S, Chatproedprai S, Kittiratsacha P. Intralesional immunotherapy using tuberculin PPD in the treatment of palmoplantar and periungual warts. Asian Biomed. 2009;3:739–743.
  • Strobel R, Rohrborn G. Mutagenic and cell transforming activities of 1-chloro 2, 4-dinitrochloro-benze (DNCB) and squaric acid dibutylester (SADBE). Arch Toxicol. 1980;45:307–314.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.